CAMK2G and polycystic kidney disease: Similar results were obtained in the cultured human epithelial cell line A549, further validating the anti-inflammatory effect mediated by HePC through the suppression of CaMKII activity, consistent with the protective mechanisms of CaMKII inhibition in polycystic kidney diseases models involving oxidative stress and apoptosis (Bracken et al., 2016).